Atul posted an adjusted profit of INR 2.5 billion for the first quarter of fiscal year 2027, marking a 92% increase compared to the same period last year. Revenue grew by 25% to INR 18.5 billion, supported by a sharp rise in the Performance and Other Chemicals segment. Investors are focused on whether this profit margin expansion can be sustained through the rest of the year.
Detailed Coverage
Atul has reported strong financial results for the first quarter ending June 2026, showcasing significant growth in both revenue and profitability. The company’s revenue for the quarter stood at INR 18.5 billion, a 25% increase from the same period in the previous year. This performance was largely supported by the Performance and Other Chemicals segment, which recorded a revenue growth of 34% year-on-year. The Life Science Chemicals segment also saw positive movement, with revenue expanding by 4% compared to the prior year.
Margin and Profitability Trends
Profitability metrics showed substantial improvement during the quarter. The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) reached INR 4 billion, representing a 67% increase year-on-year. This indicates a notable expansion in operating margins, which investors often monitor to understand how effectively a company is managing its input costs and pricing power. The adjusted profit after tax (PAT) rose to INR 2.5 billion, nearly doubling from the previous year. This jump in profit reflects the combination of higher sales volume and likely better cost management within the chemical product mix.
Valuation and Market Context
Atul currently trades at valuation multiples of approximately 21.2 times its estimated earnings per share for FY27 and 18.5 times for FY28. When looking at enterprise value relative to EBITDA, the company is trading at a forward multiple of 12.1x based on FY28 estimates. These figures provide a baseline for investors to compare the company's valuation against other players in the specialty and performance chemicals sector. Unlike some peers that have faced margin contraction due to fluctuating raw material prices or global supply chain issues, Atul’s recent performance suggests a strong competitive position in its specific product categories.
Monitoring Future Performance
While the recent results demonstrate clear growth, investors should track several factors that could influence future quarters. Key monitorables include the sustainability of the current profit margins, as chemical prices can be volatile due to global demand shifts and raw material costs. Furthermore, the pace of growth in the Life Science Chemicals segment, which saw more modest gains compared to the Performance Chemicals division, will be important for assessing the company’s overall business diversification. Any further updates on capital spending or changes in demand from key export markets will also be vital for understanding the company's path through the remainder of the fiscal year.